Inhibiting a protein involved in programmed cell death leads to reduced coronavirus replication Continue reading Coronaviruses use programmed cell death to facilitate viral replication
by Edward Chen Historical evidence shows that developing safe vaccines is necessary to protect the world from deadly diseases. But that’s only one part of the solution. After all, what’s the benefit of having vaccines that people don’t want to use? Enter vaccine hesitancy. Defined by a World Health Organization (WHO) working group as a “delay in acceptance or refusal of vaccination despite availability of … Continue reading Vaccine hesitancy: More than a pandemic
by Edward Chen The COVID-19 pandemic has catalyzed rapid technological advancements as scientists and engineers mobilize to combat its toll on human lives. Time is of the essence, and after rigorous testing for safety and effectiveness, there are now 3 vaccines with emergency approval in the United States that are all based on relatively new concepts. Two of the vaccines are based on messenger RNA … Continue reading How do COVID-19 vaccines work? Hear from a researcher who helped develop the Johnson & Johnson vaccine.
Breakthrough research published in Nucleic Acids Research suggests SARS-CoV-2-related RNA may serve as potential drug targets for COVID-19. Continue reading Preliminary Studies Point toward New COVID-19 Drug Targets
by Sam Berry In 1918, a new influenza (flu) strain infected nearly a third of the world’s population, leaving tens of millions dead. At the time, relatively little was known about this strain, later called the Spanish Flu—why it was so dangerous, how it spread, even what it was made up of. In the past 100 years, we’ve unveiled the structure of the double-helical DNA … Continue reading What Can Evolution Teach us About the Viruses of the Future?
Catherine (Xiaoxiao) Ding is a second-year Applied Math Ph.D. student in the School of Engineering and Applied Sciences at Harvard University, where she is studying programmable materials. Daniel Utter is a 5th year Ph.D. student in Organismic and Evolutionary Biology at Harvard. Continue reading Unmasking the Facts
by Apurva Govande figures by Tal Scully COVID-19, the disease caused by the newly discovered virus SARS-CoV-2, is a national emergency. We need a vaccine to prevent severe outcomes of disease, to successfully combat future outbreaks of this virus, and to ensure that businesses and schools can safely reopen. Until one is available, healthcare professionals can mitigate symptoms while deploying existing drugs that may show … Continue reading COVID-19: from treatment to prevention
by Kayla Davisfigures by Jovana Andrejevic With COVID-19 cases showing up across much of the United States, many people are increasingly curious if they have contracted the disease. Although the COVID-19 infection rate continues to rise, tests are still hard to find and nearly impossible to come by in certain areas of the country. It’s important to understand how widespread the COVID-19 infection rate is … Continue reading Better Late than Never: COVID-19 testing across the United States
The global pandemic lockdown has contributed to declines in carbon emission and is shifting the way scientists and economists discuss climate change mitigation tactics, but it’s still not enough to prevent projected temperature increases past 1.5°C.
Continue reading Global Lockdown for All – Except Carbon Emissions
